Reuters logo
in 7 months
BRIEF-Eli Lilly sees potential launch of 20 new drugs through 2023
December 15, 2016 / 4:05 PM / in 7 months

BRIEF-Eli Lilly sees potential launch of 20 new drugs through 2023

1 Min Read

Dec 15 (Reuters) - Eli Lilly And Co

* CFO says does not see U.S. healthcare reform changes impacting 2017 sales

* Eli Lilly sees potential to launch 20 new drugs between 2014 and 2023

* Eli Lilly says ending development of Fab-PEG Alzheimer's disease drug seen as similar to solanezumab

* Eli Lilly says very interested in adding to core therapeutic areas through deals for pipeline assets

* Eli lilly says early loss of U.S. exclusivity for Alimta in patent case would have significant impact on 2017 outlook Source text for Eikon: Further company coverage: (Reporting By Bill Berkrot)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below